Positive Trigger
now
Obtains comprehensive FDA clearance for its global Phase 3 trial protocol for 'XEN1101', an advanced molecular treatment targeting adult focal onset seizures.
24h Trigger History
No history available
No trigger updates found for this ticker in the last 24 hours.
| Advertisement |